SCHEMBL2002786

SCHEMBL2002786

CCCCCC1CC1C(=O)NS(=O)(=O)C1CC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.41
CYP1A2 P05177 2/20 0.41
CYP2D6 P10635 2/20 0.41
CYP2C9 P11712 2/20 0.41
CYP2C19 P33261 2/20 0.41
KDM4E B2RXH2 1/20 0.41
CYP3A4 P08684 1/20 0.41
MAPT P10636 1/20 0.41
HPGD P15428 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
ALOX5 P09917 1/20 0.40
HTT P42858 2/20 0.39
MMP1 P03956 1/20 0.37
MMP7 P09237 1/20 0.37
MMP12 P39900 1/20 0.37
ECE1 P42892 1/20 0.37
MMP13 P45452 1/20 0.37
SCN9A Q15858 1/20 0.35
NAAA Q02083 1/20 0.35
TSHR P16473 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13392664 0.89 CA1 (0.34) ALDH1A1CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL883187 0.83 NR1H4 (0.34) MMP1MMP7MMP12ECE1MMP13
Hydrochloric Acid SCHEMBL1071386 0.81 NR1H4 (0.34) MMP1MMP7MMP12ECE1MMP13
SCHEMBL8207511 0.78 ALDH1A1 (0.48) ALDH1A1CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL13071904 0.76 ALDH1A1 (0.41) ALDH1A1CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL19749138 0.73 ALDH1A1 (0.45) ALDH1A1CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL8147787 0.73 ALOX5 (0.38) ALDH1A1CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL17188775 0.73 SCN9A (0.32) SCN9A
SCHEMBL20629688 0.73 SCN9A (0.32) SCN9A
SCHEMBL7929672 0.72 NPC1 (0.34) MAPTHPGDSCN9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2337784-A1 MACROCYCLIC COMPOUNDS AS HEPATITIS C VIRUS INHIBITORS Bristol-Myers Squibb Company (US) 2011-06-29 EP disclosed
WO-2010036871-A1 MACROCYCLIC COMPOUNDS AS HEPATITIS C VIRUS INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2010-04-01 WO disclosed